About Us
Careers
Partner with us
Forgot password?
Sign in
Login
Login
Email
Password
Forgot your password?
Join VuMedi
Select specialty
Your main specialty
Adult & Family Medicine
Allergy, Asthma, Immunology
Anesthesiology
Cardiology
Dental
Dermatology
Emergency Medicine
Endocrinology
Gastroenterology & Hepatology
General Surgery
Hematology & Oncology
Infectious Disease
Medical Genetics
Nephrology
Neurology
Neurosurgery
Obstetrics/Gynecology
Ophthalmology
Oral Maxillofacial
Orthopaedics
Otolaryngology
Pathology
Pediatrics
Physical Medicine & Rehab
Plastic Surgery
Podiatry
Preventive Medicine
Psychiatry
Pulmonology
Radiation Oncology
Radiology
Rheumatology
Urology
First name
Last name
Email
Choose Password
Playback speed
0.5x
0.75x
1x (Normal)
1.25x
1.5x
1.75x
2x
10 seconds
J
Clinical Meaning of the PAOLA-1 Trial: Olaparib + Bevacizumab as 1L Maintenance in Advanced Ovarian Cancer
By
Jalid Sehouli
3 Videos
143 views
July 5, 2022
0 Comments
Login to view comments.
Click here to Login
Featured Video
04:43
Treatment Approach for Advanced Ovarian Cancer
The Role Of Folate Receptor Alpha In Ovarian Cancer
Feat.
D. M. O'Malley
Featured Video
11:42
ImmunoGen
Best Practices for the management of ocular adverse events associate…
Feat.
K. Lamoreau
Related Content
AUTOPLAY
ON
09:06
2024 ASCO® Annual Meeting Insights Hub
ASCO® 2024 Summary: "Gynecologic Oncology Updates"
Feat.
R. Salani
09:55
2024 ASCO® Annual Meeting Insights Hub
ASCO® 2024 Insights: "The ABCs of ADCs - What Does the Future H…
Feat.
E. Hamilton
17:50
AdventHealth
Clinical Highlights From AACR 2024: Trials Evaluating Selected New T…
Feat.
G. Sonpavde
27:04
Fengting Yan
Cancer Screening Molecular Tools
14:45
2024 ASCO® Annual Meeting Insights Hub
ASCO® 2024 Summary: "Gynecological Cancers Highlights"
Feat.
M. Raza Mirza
08:52
2024 ESMO Annual Meeting Insights Hub
ESMO 2024 Insights: Final OS With Niraparib as 1L Maintenance in Adv…
Feat.
B. Monk
11:15
Total Health
2024 Updates in Ovarian Cancer
Feat.
T. Tillmanns
13:15
2024 ASCO® Annual Meeting Insights Hub
ASCO® 2024 Summary: "Timing of Debulking Surgery in Advanced En…
Feat.
A. Karam
15:45
Michael Birrer
Defining Platinum Resistance in Ovarian Cancer
27:14
David Tan
Management of Recurrent Ovarian Clear Cell Carcinoma
06:07
Insights from 2023 ESMO Annual Meeting
ESMO 2023 Summary: "Key Updates in Gynecological Cancers"
Feat.
M. Raza Mirza
13:14
2024 ESMO Annual Meeting Insights Hub
ESMO 2024 Insights: Rucaparib +/- Nivo as Maintenance in Newly Diagn…
Feat.
B. Monk
17:20
UCLA Health
Antibody Drug Conjugates in Gynecologic Oncology: From Bench to Beds…
Feat.
G. Konecny
06:50
Fengting Yan
Year in Review: Ovarian Cancer
19:30
Miami Cancer Institute Precision Oncology Symposium
Precision Oncology in the Management of Ovarian Cancer
Feat.
D. Dizon
15:14
Brian Slomovitz
Update in Vulvar and Vaginal Cancer
23:53
Masonic Cancer Center, University of Minnesota
Overview of Ovarian Cancer Updates
Feat.
J. Mattson
25:10
Yale School of Medicine
Ovarian Cancer Prevention and Early Detection - Ovarian Cancer Does …
Feat.
M. Minkin,
E. Ratner
18:16
Insights from 2024 ESGO Annual Meeting
ESGO 2024 Insights: "Antibody-Drug Conjugates in Ovarian Cancer…
Feat.
J. Kurtz
12:56
UChicago Medicine Annual Practice Updates in Hematology and Oncology
UChicago Medicine Best of ASCO® 2024: Options for Recurrent Platinum…
Feat.
H. Cun
